{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:07Z","timestamp":1792787287506,"version":"4.5.0"},"reference-count":51,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100668"],"award-info":[{"award-number":["82100668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82121001"],"award-info":[{"award-number":["82121001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200684"],"award-info":[{"award-number":["82200684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370633"],"award-info":[{"award-number":["82370633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wuxi Taihu Lake Talent Plan for Leading Talents in Medical and Health Profession","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221032"],"award-info":[{"award-number":["BK20221032"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,12,15]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Liver fibrosis is a prelude to a host of end-stage liver diseases. Hepatic stellate cells (HSCs), switching from a quiescent state to myofibroblasts, are the major source for excessive production of extracellular matrix proteins. In the present study, we investigated the role of Suv39h1, a lysine methyltransferase, in HSC-myofibroblast transition and the implication in liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      HSC-specific or myofibroblast-specific Suv39h1 deletion was achieved by crossbreeding the\n                      <jats:italic>Suv39h1<\/jats:italic>\n                      <jats:sup>f\/f<\/jats:sup>\n                      mice to the\n                      <jats:italic>Lrat<\/jats:italic>\n                      -Cre mice or the\n                      <jats:italic>Postn<\/jats:italic>\n                      -Cre\n                      <jats:sup>ERT2<\/jats:sup>\n                      mice. Liver fibrosis was induced by CCl\n                      <jats:sub>4<\/jats:sub>\n                      injection or bile duct ligation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We report that Suv39h1 expression was universally upregulated during HSC-myofibroblast transition in different cell and animal models of liver fibrosis and in human cirrhotic liver tissues. Consistently, Suv39h1 knockdown blocked HSC-myofibroblast transition in vitro. HSC-specific or myofibroblast-specific deletion of Suv39h1 ameliorated liver fibrosis in mice. More importantly, Suv39h1 inhibition by a small-molecule compound chaetocin dampened HSC-myofibroblast transition in cell culture and mitigated liver fibrosis in mice. Mechanistically, Suv39h1 bound to the promoter of heme oxygenase 1 (HMOX1) and repressed HMOX1 transcription. HMOX1 depletion blunted the effects of Suv39h1 inhibition on HSC-myofibroblast transition in vitro and liver fibrosis in vivo. Transcriptomic analysis revealed that HMOX1 might contribute to HSC-myofibroblast transition by modulating retinol homeostasis. Finally, myofibroblast-specific HMOX1 overexpression attenuated liver fibrosis in both a preventive scheme and a therapeutic scheme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data demonstrate a previously unrecognised role for Suv39h1 in liver fibrosis and offer proof-of-concept of its targetability in the intervention of cirrhosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-329671","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:35:42Z","timestamp":1704846942000},"page":"810-824","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis"],"prefix":"10.1136","volume":"73","author":[{"given":"Ming","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoqi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Kuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-9371","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"2024071803150620000_73.5.810.1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3623"},{"key":"2024071803150620000_73.5.810.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27332"},{"key":"2024071803150620000_73.5.810.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.97"},{"key":"2024071803150620000_73.5.810.4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"2024071803150620000_73.5.810.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28948"},{"key":"2024071803150620000_73.5.810.6","first-page":"131","article-title":"Dupuytren\u2019s Contracture: fibroblast contraction? an ultrastructural study","volume":"66","author":"Gabbiani","year":"1972","journal-title":"Am J Pathol"},{"key":"2024071803150620000_73.5.810.7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic Stellate cells as dominant contributors to liver fibrosis independent of its Aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"2024071803150620000_73.5.810.8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31987"},{"key":"2024071803150620000_73.5.810.9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.14348\/molcells.2022.0001","article-title":"The Chromatin accessibility landscape of Nonalcoholic fatty liver disease progression","volume":"45","author":"Kang","year":"2022","journal-title":"Mol Cells"},{"key":"2024071803150620000_73.5.810.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.027"},{"key":"2024071803150620000_73.5.810.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-021-08173-1","article-title":"Multi-Omics analyses of early liver injury reveals cell-type-specific transcriptional and Epigenomic shift","volume":"22","author":"Migda\u0142","year":"2021","journal-title":"BMC Genomics"},{"key":"2024071803150620000_73.5.810.12","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/528S12a","article-title":"Epigenetics: the genome unwrapped","volume":"528","author":"Ledford","year":"2015","journal-title":"Nature"},{"key":"2024071803150620000_73.5.810.13","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.7.1923"},{"key":"2024071803150620000_73.5.810.14","doi-asserted-by":"publisher","DOI":"10.1038\/35020506"},{"key":"2024071803150620000_73.5.810.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00542-6"},{"key":"2024071803150620000_73.5.810.16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14941","article-title":"The Histone H3K9 methyltransferase Suv39H links Sirt1 repression to myocardial infarction","volume":"8","author":"Yang","year":"2017","journal-title":"Nat Commun"},{"key":"2024071803150620000_73.5.810.17","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0885"},{"key":"2024071803150620000_73.5.810.18","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.169"},{"key":"2024071803150620000_73.5.810.19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94753"},{"key":"2024071803150620000_73.5.810.20","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101957","article-title":"Ddit4 S-Nitrosylation AIDS P38-MAPK signaling complex assembly to promote hepatic reactive oxygen species production","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"2024071803150620000_73.5.810.21","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.688","article-title":"Myocardin-related transcription factor A drives ROS-fueled expansion of hepatic Stellate cells by regulating P38-MAPK signalling","volume":"12","author":"Dong","year":"2022","journal-title":"Clin Transl Med"},{"key":"2024071803150620000_73.5.810.22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.stem.2016.05.005","article-title":"In vivo hepatic Reprogramming of Myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis","volume":"18","author":"Rezvani","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2024071803150620000_73.5.810.23","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2016.20"},{"key":"2024071803150620000_73.5.810.24","doi-asserted-by":"crossref","first-page":"680344","DOI":"10.3389\/fcell.2021.680344","article-title":"Down-regulation of Cxxc5 de-represses Mycl1 to promote hepatic Stellate cell activation","volume":"9","author":"Wu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024071803150620000_73.5.810.25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-1-0716-2010-6_27","article-title":"Protocol for isolation and culture of Mouse hepatocytes (Hcs), Kupffer cells (KCs), and liver sinusoidal endothelial cells (Lsecs) in analyses of hepatic drug distribution","volume":"2434","author":"Elvevold","year":"2022","journal-title":"Methods Mol Biol"},{"key":"2024071803150620000_73.5.810.26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvab110","article-title":"Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice","volume":"118","author":"Liu","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024071803150620000_73.5.810.27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41419-022-04944-0","article-title":"Trans-activation of Eotaxin-1 by Brg1 contributes to liver regeneration","volume":"13","author":"Fan","year":"2022","journal-title":"Cell Death Dis"},{"key":"2024071803150620000_73.5.810.28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622866","article-title":"The Chromatin remodeling protein Brg1 regulates SREBP maturation by activating SCAP transcription in hepatocytes","volume":"9","author":"Kong","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024071803150620000_73.5.810.29","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio721"},{"key":"2024071803150620000_73.5.810.30","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.38"},{"key":"2024071803150620000_73.5.810.31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005761"},{"key":"2024071803150620000_73.5.810.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001372","article-title":"A Ribosomal S-6 kinase-mediated signal to C\/EBP-beta is critical for the development of liver fibrosis","volume":"2","author":"Buck","year":"2007","journal-title":"PLoS One"},{"key":"2024071803150620000_73.5.810.33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2016.08.006","article-title":"Steatosis induced Ccl5 contributes to early-stage liver fibrosis in Nonalcoholic fatty liver disease progress","volume":"180","author":"Li","year":"2017","journal-title":"Transl Res"},{"key":"2024071803150620000_73.5.810.34","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced Steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J Hepatol"},{"key":"2024071803150620000_73.5.810.35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/leu.2016.16","article-title":"An Isoform-specific C\/Ebpbeta inhibitor targets acute myeloid leukemia cells","volume":"30","author":"Jakobs","year":"2016","journal-title":"Leukemia"},{"key":"2024071803150620000_73.5.810.36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.bbamcr.2017.05.003","article-title":"Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C\/Ebpbeta","volume":"1864","author":"Falkenberg","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2024071803150620000_73.5.810.37","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00070-14"},{"key":"2024071803150620000_73.5.810.38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410078200"},{"key":"2024071803150620000_73.5.810.39","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2017.1281502"},{"key":"2024071803150620000_73.5.810.40","doi-asserted-by":"publisher","DOI":"10.1038\/nature13193"},{"key":"2024071803150620000_73.5.810.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.06.049"},{"key":"2024071803150620000_73.5.810.42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1018"},{"key":"2024071803150620000_73.5.810.43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023171"},{"key":"2024071803150620000_73.5.810.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00906-5"},{"key":"2024071803150620000_73.5.810.45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24711"},{"key":"2024071803150620000_73.5.810.46","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104983","article-title":"Heme Oxygenase-1 mitigates liver injury and fibrosis via modulation of Lnx1\/Notch1 pathway in myeloid cells","volume":"25","author":"Canesin","year":"2022","journal-title":"iScience"},{"key":"2024071803150620000_73.5.810.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.026"},{"key":"2024071803150620000_73.5.810.48","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.142638"},{"key":"2024071803150620000_73.5.810.49","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ccell.2023.05.005","article-title":"Methionine restriction promotes cGAS activation and Chromatin Untethering through Demethylation to enhance antitumor immunity","volume":"41","author":"Fang","year":"2023","journal-title":"Cancer Cell"},{"key":"2024071803150620000_73.5.810.50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1039\/D1CB00196E","article-title":"Lysine methyltransferase inhibitors: where we are now","volume":"3","author":"Feoli","year":"2022","journal-title":"RSC Chem Biol"},{"key":"2024071803150620000_73.5.810.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05289-6"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-329671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T13:03:18Z","timestamp":1721307798000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-329671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,5]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/gutjnl-2023-329671"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-329671","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]}}}